Azzam I, Kovalev Y, Storch S, Elias N
Department of Internal Medicine A, Bnai Zion Medical Center, Haifa 31048, PO Box 4940, Israel.
Postgrad Med J. 2004 Aug;80(946):487-8. doi: 10.1136/pgmj.2003.017244.
An elderly woman developed severe hyperphosphataemia, hypocalcaemia, and cardiac arrest after oral administration of sodium phosphate in preparation for colonoscopy. This is an unusual complication and is attributed to decreased phosphate excretion by the kidneys. At increased risk are patients with impaired renal function, age more than 65 years, and presenting with intestinal obstruction or decreased intestinal motility, increased intestinal permeability, liver cirrhosis, or congestive heart failure. Though there are no accepted guidelines for anticipation and prevention of this adverse effect, it may be desirable to check serum phosphate concentrations before choosing the method for colonic preparation and before giving the second oral dose of sodium phosphate in patients at risk. Hyperphosphataemia should be suspected if a patient develops hypotension or neuromuscular irritability after administration of sodium phosphate. Haemodialysis for direct removal of phosphate and intravenous calcium for treatment of symptomatic hypocalcaemia may be life saving.
一名老年女性在口服磷酸钠为结肠镜检查做准备后出现严重高磷血症、低钙血症和心脏骤停。这是一种不寻常的并发症,归因于肾脏排磷减少。肾功能受损、年龄超过65岁、伴有肠梗阻或肠道蠕动减弱、肠道通透性增加、肝硬化或充血性心力衰竭的患者风险增加。尽管对于这种不良反应的预测和预防尚无公认的指南,但对于有风险的患者,在选择结肠准备方法之前以及给予第二剂口服磷酸钠之前,检查血清磷酸盐浓度可能是可取的。如果患者在服用磷酸钠后出现低血压或神经肌肉兴奋性增加,应怀疑高磷血症。通过血液透析直接清除磷酸盐以及静脉注射钙剂治疗有症状的低钙血症可能挽救生命。